Central stimulant use in ADHD a burden in the US

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.436, 2003-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Central stimulant prescribing for ADHD variable in WA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 526, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

ADHD poses a significant burden among US adults

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

ADHD poses a significant burden among US adults

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Healthcare Use, Social Burden and Costs of Children With and Without ADHD in Flanders, Belgium

By Annemieke De Ridder Diana De Graeve

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 75-90

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD

By Dew Rachel E Kollins Scott H

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 17, 2010-12 ,pp. : 2907-2913

Informa Healthcare

Access to resources Recommend Favorite